BioSpace News Archive

Researchers at the University of New Hampshire have created an easy-to-make, low-cost injectable hydrogel that could help wounds heal faster, especially for patients with compromised health issues.

New therapeutic combination is expected to be generally applicable to many solid tumors with high unmet medical need

Abu Dhabi Smart Solutions and Services Authority, in collaboration with the Abu Dhabi Health Services Company (SEHA), organized a seasonal influenza vaccination campaign for its employees as a preventive measure to contain the spread of influenza virus at this time of the year.

Peptinnovate Ltd announces that it has changed its corporate name from Peptinnovate to Immune Regulation with immediate effect. The new website for Immune Regulation is www.immuneregulation.com.

Galapagos NV announces a share capital increase arising from warrant exercises.

Eisai Co., Ltd. announced that the latest data on its antiepileptic drug (AED) perampanel (product name: Fycompa) will be presented at the 72nd American Epilepsy Society Annual Meeting (AES 2018) to be held from November 30 to December 4, 2018 in New Orleans in the United States.

Next step: Developing therapies to restore the gene product

Trial of CD22-targeting antibody drug conjugate being led by The University of Texas MD Anderson Cancer Center

Bill Wright, who most recently led SynDaver’s European operations, has assumed global responsibilities previously managed by SynDaver CEO, Dr. Christopher Sakezles. This leadership change will enable Sakezles to be wholly focused on SynDaver’s new research and development operations under sister company, SynDaverX.

In collaboration with researchers at Vancouver Prostate Centre in Canada, Glactone Pharma has discovered a novel way of enhancing the effects of current prostate cancer treatments.